Skip to content

Advertisement

Open Access

Erratum to: JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI

  • Li-Liang Li1,
  • Ai-Min Xue1,
  • Bei-Xu Li1,
  • Yi-Wen Shen1,
  • Yu-Hua Li1,
  • Cheng-Liang Luo1,
  • Ming-Chang Zhang1,
  • Jie-Qing Jiang1,
  • Zu-De Xu2,
  • Jian-Hui Xie1Email author and
  • Zi-Qin Zhao1Email author
Contributed equally
Breast Cancer Research201618:114

https://doi.org/10.1186/s13058-016-0776-3

Received: 9 November 2016

Accepted: 9 November 2016

Published: 21 November 2016

The original article was published in Breast Cancer Research 2014 16:R56

In the original publication of the article [1], we noticed an error to Table 2. The numbers for each ARHI staining in the subtypes of JMJD2A were mistakenly copied from another molecular which we were simultaneously working on. This mistake went unfortunately unnoticed in the thereafter review and proofreading processes. The Table 2 shown in this erratum is the correct representation of the data from this study. The authors apologize for this error.
Table 2

Association between JMJD2A expression and clinicopathological parameters in 155 cases of breast cancers

 

Total

JMJD2A

P -value

Correlation coefficient

0(-) n = 11

1(+) n = 56

2(++) n = 53

3(+++) n = 35

ERα

       

 Negative

52

4

18

17

13

0.778

-0.023

 positive

103

7

38

36

22

PR

       

 Negative

77

7

22

26

22

0.147

-0.117

 positive

78

4

34

27

13

HER2

       

 Negative

7

0

3

2

2

0.742

-0.027

 Positive

148

11

53

51

33

ARHI

       

 Negative

63

3

18

23

19

0.021*

-0.185

 Positive

92

8

38

30

16

* p <0.05

As a consequence, the sentence in the left column of Page 6 of 14 of the article PDF, line 4-6, should be accordingly corrected to be “Spearman correlation analysis showed that expression of JMJD2A was inversely correlated with expression of ARHI (p = 0.021, r = -0.185, Table 2)”.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Forensic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of China
(2)
Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of China

References

  1. Li et al. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI. Breast Cancer Research. 2014; 16:R56Google Scholar

Copyright

© The Author(s). 2016

Advertisement